Latest Balance Sheet News

Visionflex Group reported an 8% increase in Annual Recurring Revenue to $1.6 million in Q2 FY25 despite an 11% revenue decline, securing key contracts with Spark Health, BUPA, and Indigenous Wellness Connect. The company targets EBITDA profitability by Q4 FY25 amid a maturing sales pipeline.

IGO's December quarter report reveals robust performance at Greenbushes lithium mine but significant setbacks at Kwinana and Nova, culminating in a $79 million EBITDA loss and a strategic halt on Kwinana’s Plant 2.

Champion Iron Limited reported robust financial results for the nine months ended December 31, 2024, alongside a strategic partnership to develop its Kami Project with Nippon Steel and Sojitz.

Strickland Metals has reported exceptional drilling results from its Rogozna Project in Serbia and Yandal Project in Western Australia, alongside a robust financial footing to support ongoing exploration.

Titan Minerals reports standout drilling results at its Dynasty Gold Project’s Iguana prospect, confirming resource growth potential with significant gold and silver intercepts. The company is advancing its 10,000m drilling campaign backed by a strong balance sheet.

Patronus Resources reports significant drilling progress across its Western Australia and Northern Territory projects, with strong assay results at Mertondale and a robust cash position supporting ongoing exploration.

Imagion Biosystems has secured a AU$3 million capital injection and resumed its collaboration with Siemens, setting the stage to prioritize FDA filings and advance its MagSense® HER2 breast cancer imaging program.

Locality Planning Energy Holdings (LPE) reports a cashflow positive half-year and reduces debt, while securing a landmark energy management contract for Queensland's largest social housing project.

Delta Lithium reports robust December quarter results with significant gold drilling successes at Mt Ida and progress on lithium development at Yinnetharra, alongside strategic leadership changes and asset sales.

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

Asset Vision Co Limited has reported a robust Q2 FY25, marked by significant revenue growth, improved cash flow, and effective cost management, positioning the company well for continued expansion.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.